These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23774878)

  • 1. Is it time for treatment as prevention among people who inject drugs?
    Bruce RD
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):545-7. PubMed ID: 23774878
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral therapy for prevention of HIV transmission: potential role for people who inject drugs in Central Asia.
    McNairy ML; Deryabina A; Hoos D; El-Sadr WM
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S65-70. PubMed ID: 23880248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Service integration: opportunities to expand access to antiretroviral therapy for people who inject drugs in Tanzania.
    Lambdin BH; Mbwambo JK; Josiah RM; Bruce RD
    J Int AIDS Soc; 2015; 18(1):19936. PubMed ID: 26202669
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of HIV prevention interventions for people who inject drugs in low- and middle-income countries--the current and future state of the art.
    Hammett TM; Parsons DS
    Int J Drug Policy; 2014 May; 25(3):336-9. PubMed ID: 24559603
    [No Abstract]   [Full Text] [Related]  

  • 5. People who inject drugs in prison: HIV prevalence, transmission and prevention.
    Dolan K; Moazen B; Noori A; Rahimzadeh S; Farzadfar F; Hariga F
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S12-5. PubMed ID: 25727258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current world literature.
    Curr Opin HIV AIDS; 2012 Jul; 7(4):376-81. PubMed ID: 22678490
    [No Abstract]   [Full Text] [Related]  

  • 7. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services.
    Getahun H; Gunneberg C; Sculier D; Verster A; Raviglione M
    Curr Opin HIV AIDS; 2012 Jul; 7(4):345-53. PubMed ID: 22678489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low PrEP Awareness and Use Among People Who Inject Drugs, San Francisco, 2018.
    McFarland W; Lin J; Santos GM; Arayasirikul S; Raymond HF; Wilson E
    AIDS Behav; 2020 May; 24(5):1290-1293. PubMed ID: 31563984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on biomedical HIV prevention options among women who inject drugs in Kenya.
    Bazzi AR; Yotebieng KA; Agot K; Rota G; Syvertsen JL
    AIDS Care; 2018 Mar; 30(3):343-346. PubMed ID: 28780885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV/AIDS in India. The needle and the damage done.
    Cohen J
    Science; 2004 Apr; 304(5670):509-12. PubMed ID: 15105472
    [No Abstract]   [Full Text] [Related]  

  • 12. A collision of crises: Addressing an HIV outbreak among people who inject drugs in the midst of COVID-19.
    Taylor JL; Ruiz-Mercado G; Sperring H; Bazzi AR
    J Subst Abuse Treat; 2021 May; 124():108280. PubMed ID: 33771280
    [No Abstract]   [Full Text] [Related]  

  • 13. PEPFAR's evolving HIV prevention approaches for key populations--people who inject drugs, men who have sex with men, and sex workers: progress, challenges, and opportunities.
    Needle R; Fu J; Beyrer C; Loo V; Abdul-Quader AS; McIntyre JA; Li Z; Mbwambo JK; Muthui M; Pick B
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S145-51. PubMed ID: 22797736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology of HIV].
    Ledergerber B; Battegay M
    Ther Umsch; 2014 Aug; 71(8):437-41. PubMed ID: 25093307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Hershow RB; Gonzalez M; Costenbader E; Zule W; Golin C; Brinkley-Rubinstein L
    AIDS Educ Prev; 2019 Aug; 31(4):363-379. PubMed ID: 31361517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
    Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
    Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment as prevention among injecting drug users; extrapolating from the Amsterdam cohort study.
    de Vos AS; Prins M; Coutinho RA; van der Helm JJ; Kretzschmar ME
    AIDS; 2014 Mar; 28(6):911-8. PubMed ID: 24401639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late for the epidemic: HIV/AIDS in Eastern Europe.
    Cohen J
    Science; 2010 Jul; 329(5988):160, 162-4. PubMed ID: 20616262
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV Reduction Among Women Who Inject Drugs Can Be Achieved Through Women-Specific Programs and Global Targets: A Model From Ukraine.
    Deshko T
    J Acquir Immune Defic Syndr; 2015 Jun; 69 Suppl 2():S98-9. PubMed ID: 25978490
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of neglect and stigmatisation on post-therapy behaviour of patients who are HIV-positive.
    Hemmat N; Bannazadeh Baghi H
    Sex Transm Infect; 2019 Nov; 95(7):548. PubMed ID: 31628261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.